Zomedica Corp. has announced an exclusive agreement to market Cresilon’s revolutionary Vetigel® hemostatic gel in the U.S., marking a significant expansion of its veterinary health portfolio.

Liam Kelly, Chairman, President, and CEO of Teleflex Incorporated, is set to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025. The presentation will be available via live audio webcast on the Teleflex investor website, offering insights into the company’s mission to improve global health.

SpringWorks Therapeutics’ CEO, Saqib Islam, is set to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025. The announcement follows the company’s recent FDA approval of their first therapy, OGSIVEO®, marking a significant milestone in their mission to treat severe rare diseases and cancer.

As Chinese-made drones dominate U.S. skies, Congress moves to halt new sales, citing espionage fears and a struggling domestic industry. This legislative push reflects the growing technological rivalry between the United States and China.

Despite advanced software, harmful medication errors persist with current infusion pumps. The innovative Ivenix system aims to change that by enhancing drug delivery efficiency and patient safety.